Home » Topics » Merck KGaA
Merk suffers setback on lung cancer treatment
German pharmaceuticals maker Merck KGaA said Tuesday it is withdrawing its application for its drug Erbitux to be used to treat patients with lung cancer. Merck said in a statement it had decided to “voluntarily withdraw the marketing authorisation application to the European Medicines Agency” for Erbitux to be used…
Brand new on Raw Story
- Mall ejects sisters over ‘Fu*k Cancer’ shirts days after mom’s death
- LGBT groups slam same-sex couples’ exclusion from immigration reform
- NYPD data: Whites much more likely to be carrying drugs and guns than minorities
- Ted Cruz: ‘I don’t trust the Republicans’
- UN secretary general warns the world is on track to run out of drinkable water
- Spanish flamenco dancing to celebrate origins in India
- France debates teaching more courses in English at universities
- Virginia lt. gov. nominee: Not sorry for hate speech ‘because I’m a Christian’
- Japanese specialist tests non-surgical ‘heavy ion radiotherapy’ breast cancer therapy
- Italian lawmakers approve controversial stem cell therapy
Commentary
Tone policing only goes one way
By Amanda Marcotte
The Orange Couch does Mad Men: S7E8, “The Crash”
By Amanda Marcotte
An open letter to the Center for Inquiry
By Amanda Marcotte
Raw Exclusives
Featured Video
Follow Us!
